BUSINESS● LOW4d ago · Oct 28, 2026, 3:57 PM
Sellas falls as REGAL trial nears final analysis
Seeking Alpha Tech · global
Sellas stock has declined as its REGAL trial approaches final analysis. This suggests investor reaction to anticipated results from a clinical trial.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS21m agoSam Altman makes surprise South Korea visit as OpenAI builds on chip partnershipsCNBCBUSINESS1h agoWhat can Cambridge teach Hong Kong about building university towns?South China Morning Post